Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
A Sharp Decline From Evernorths Peak Coverage Rate Roughly 50% of Evernorths clients had covered GLP-1s for weight loss as of May 2025, meaning the current downtick represents a meaningful pullback from a much higher coverage rate just over a year earlier, even though the article does not specify the current exact percentage
Semaglutide and liraglutide are both in a class of medicines known as glucagon-like peptide-1 (GLP-1) receptor agonists
Presented for research literature review only Ketterer B (1986)
-55% CELLUCOR CarnoSyn Beta-Alanine 11.04 / 21.59
US$ 29.34
US$ 25.55
US$ 20.12
US$ 29.88
US$ 29.53
